tiprankstipranks
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
India Market
AARTIDRUGS
Aarti Drugs Limited
RESEARCH TOOLSreports

Aarti Drugs Limited (AARTIDRUGS) Ratios

3 Followers

Aarti Drugs Limited Ratios

IN:AARTIDRUGS's free cash flow for Q2 2026 was ₹0.37. For the 2026 fiscal year, IN:AARTIDRUGS's free cash flow was decreased by ₹ and operating cash flow was ₹0.10. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.68 1.60 1.66 1.57 1.48
Quick Ratio
 1.08 1.03 1.05 1.03 0.92
Cash Ratio
 <0.01 <0.01 <0.01 <0.01 0.02
Solvency Ratio
 0.23 0.19 0.19 0.18 0.22
Operating Cash Flow Ratio
 0.19 0.29 0.45 0.14 0.07
Short-Term Operating Cash Flow Coverage
 0.51 0.75 1.25 0.33 0.17
Net Current Asset Value
₹ 1.69B₹ 1.33B₹ 1.70B₹ 2.64B₹ 2.22B
Leverage Ratios
Debt-to-Assets Ratio
 0.22 0.24 0.23 0.25 0.25
Debt-to-Equity Ratio
 0.39 0.45 0.44 0.51 0.52
Debt-to-Capital Ratio
 0.28 0.31 0.31 0.34 0.34
Long-Term Debt-to-Capital Ratio
 0.16 0.17 0.18 0.15 0.12
Financial Leverage Ratio
 1.78 1.88 1.90 2.03 2.13
Debt Service Coverage Ratio
 0.90 0.67 0.80 0.58 0.66
Interest Coverage Ratio
 10.75 20.43 7.09 7.13 12.06
Debt to Market Cap
 0.18 0.19 0.13 0.19 0.14
Interest Debt Per Share
 66.64 71.03 65.20 69.77 61.20
Net Debt to EBITDA
 1.83 2.12 1.72 1.93 1.51
Profitability Margins
Gross Profit Margin
34.32%35.40%33.65%13.59%15.62%
EBIT Margin
9.77%9.69%10.81%9.62%11.81%
EBITDA Margin
12.26%12.03%12.85%11.47%13.82%
Operating Profit Margin
14.79%30.70%10.62%9.75%11.59%
Pretax Profit Margin
8.39%8.87%9.31%8.25%10.85%
Net Profit Margin
8.03%7.04%6.78%6.12%8.24%
Continuous Operations Profit Margin
8.03%7.04%6.79%6.12%8.24%
Net Income Per EBT
95.70%79.40%72.78%74.19%75.95%
EBT Per EBIT
56.76%28.90%87.67%84.65%93.61%
Return on Assets (ROA)
7.76%6.53%7.05%6.87%9.29%
Return on Equity (ROE)
14.78%12.28%13.38%13.95%19.78%
Return on Capital Employed (ROCE)
20.39%42.17%16.41%17.99%22.75%
Return on Invested Capital (ROIC)
16.76%28.14%10.17%10.48%13.11%
Return on Tangible Assets
7.78%6.55%7.16%6.87%9.29%
Earnings Yield
6.29%5.35%4.06%5.32%5.16%
Efficiency Ratios
Receivables Turnover
 3.50 3.17 3.59 3.12 3.21
Payables Turnover
 4.40 3.71 3.73 3.83 4.48
Inventory Turnover
 3.52 3.26 3.45 3.66 3.99
Fixed Asset Turnover
 2.02 2.01 2.40 3.07 3.25
Asset Turnover
 0.97 0.93 1.04 1.12 1.13
Working Capital Turnover Ratio
 9.52 4.65 4.73 5.45 5.44
Cash Conversion Cycle
 124.77 128.42 109.60 121.70 123.57
Days of Sales Outstanding
 104.22 114.98 101.70 117.11 113.62
Days of Inventory Outstanding
 103.58 111.94 105.71 99.79 91.41
Days of Payables Outstanding
 83.03 98.50 97.82 95.19 81.46
Operating Cycle
 207.80 226.92 207.41 216.89 205.03
Cash Flow Ratios
Operating Cash Flow Per Share
 16.69 26.69 38.86 14.49 7.52
Free Cash Flow Per Share
 6.36 7.36 14.36 -3.29 -8.89
CapEx Per Share
 10.33 19.33 24.51 17.78 16.41
Free Cash Flow to Operating Cash Flow
 0.38 0.28 0.37 -0.23 -1.18
Dividend Paid and CapEx Coverage Ratio
 1.62 1.31 1.52 0.77 0.43
Capital Expenditure Coverage Ratio
 1.62 1.38 1.59 0.81 0.46
Operating Cash Flow Coverage Ratio
 0.27 0.40 0.64 0.22 0.13
Operating Cash Flow to Sales Ratio
 0.06 0.10 0.14 0.05 0.03
Free Cash Flow Yield
1.80%2.14%3.14%-0.97%-2.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.90 18.70 24.64 18.81 19.38
Price-to-Sales (P/S) Ratio
 1.28 1.32 1.67 1.15 1.60
Price-to-Book (P/B) Ratio
 2.19 2.30 3.30 2.62 3.83
Price-to-Free Cash Flow (P/FCF) Ratio
 55.49 46.64 31.86 -102.64 -48.26
Price-to-Operating Cash Flow Ratio
 21.14 12.86 11.77 23.31 57.06
Price-to-Earnings Growth (PEG) Ratio
 9.12 -16.53 7.38 -1.00 -0.73
Price-to-Fair Value
 2.19 2.30 3.30 2.62 3.83
Enterprise Value Multiple
 12.25 13.07 14.72 11.96 13.07
Enterprise Value
 37.88B 37.52B 47.82B 37.28B 44.94B
EV to EBITDA
 12.25 13.07 14.72 11.96 13.07
EV to Sales
 1.50 1.57 1.89 1.37 1.81
EV to Free Cash Flow
 65.25 55.65 36.07 -122.33 -54.58
EV to Operating Cash Flow
 24.86 15.34 13.32 27.78 64.54
Tangible Book Value Per Share
 159.82 148.65 134.81 128.71 111.90
Shareholders’ Equity Per Share
 160.87 149.39 138.76 128.77 111.92
Tax and Other Ratios
Effective Tax Rate
 0.04 0.21 0.27 0.26 0.24
Revenue Per Share
 276.30 260.48 273.77 293.31 268.75
Net Income Per Share
 22.20 18.35 18.56 17.96 22.14
Tax Burden
 0.96 0.79 0.73 0.74 0.76
Interest Burden
 0.86 0.92 0.86 0.86 0.92
Research & Development to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.01 0.05 0.04 0.03 0.03
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.60 1.45 2.09 0.60 0.26
Currency in INR